Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Kissei Pharmaceutical Co., Ltd. clinical trials
The registry lists 63 studies whose lead sponsor is Kissei Pharmaceutical Co., Ltd.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 10, 2026.
Keep track of what changes. Save the Kissei Pharmaceutical Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Kissei Pharmaceutical Co., Ltd..
- Kissei Pharmaceutical Co., Ltd.63 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 →
- A Clinical Trial of Olutasidenib in Patients With Acute Myeloid LeukemiaRecruitingNCT07604064Phase 2
- Special Drug Use-results Survey for Long-term Use(Avacopan)RecruitingNCT06758271
- Special Drug Use-results Survey for Long-term Use (Fostamatinib)RecruitingNCT06757257
- A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's DiseaseCompletedNCT06722729Phase 2
- Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar DegenerationActive, not recruitingNCT07040137Phase 3
- A Clinical Study of KLH-2109 in Patients With EndometriosisActive, not recruitingNCT07015268Phase 3
- A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.CompletedNCT03802617Phase 2
- A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and PainCompletedNCT05445167Phase 3
- A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.CompletedNCT04711603Phase 3
- A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788CompletedNCT04132050Phase 3
- Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)CompletedNCT04335591Phase 3
- A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated PainTerminatedNCT03986944Phase 3
- Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.CompletedNCT03992846Phase 3
- Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated PainTerminatedNCT04372121Phase 3
- An Early Phase 2 Clinical Study of KSP-0243CompletedNCT05831670Phase 2
- A Clinical Study of KLH-2109 in Uterine Fibroids Patient With MenorrhagiaCompletedNCT05440383Phase 3
- A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseCompletedNCT04867551Phase 2
- A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.CompletedNCT03845387Phase 2
- Clinical Study of YS110 in Patients With Malignant Pleural MesotheliomaCompletedNCT03177668Phase 1/2
- Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes MellitusCompletedNCT02154347Phase 4
- Late Phase II Clinical Study of KLH-2109 in Patients With EndometriosisCompletedNCT02778919Phase 2
- A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)CompletedNCT02912494Phase 3
- A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)CompletedNCT02912533Phase 3
- Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's DiseaseCompletedNCT03068481Phase 1
- An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT02889302Phase 3
- A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970098Phase 3
- A Long-term Study of PA21 in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01833494Phase 3
- A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01850641Phase 3
- A Phase III Study of PA21 in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01850602Phase 3
- PA21 Phase II Clinical Study in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01521494Phase 2
- An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeTerminatedNCT02503176Phase 3
- A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503163Phase 3
- Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)CompletedNCT02281630Phase 2
- Phase II Study of KWA-0711 in Patients With Chronic Constipation (CC)CompletedNCT02343978Phase 2
- A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503189Phase 3
- Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male SubjectsCompletedNCT02434835Phase 1
- A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970124Phase 3
- A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970137Phase 3
- An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)CompletedNCT01970111Phase 3
- Phase II Exploratory Clinical Study of KUX-1151CompletedNCT02190786Phase 2
- A Late Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01890941Phase 2
- A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer AgentsCompletedNCT01596088Phase 1/2
- Long-term Study of KAD-1229 in Type 2 Diabetes PatientsCompletedNCT01333592Phase 3
- A Phase III Study of PA21 in Peritoneal Dialysis Patients With HyperphosphatemiaCompletedNCT01852682Phase 3
- A Single-blind, Dose-tapering Study of KWA-0711 in Patients With Chronic ConstipationCompletedNCT01937663Phase 2
- A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic ConstipationCompletedNCT01938196Phase 2
- A Phase II Randomized Open Label Study of KLH-2109 in Patients With EndometriosisCompletedNCT01629420Phase 2
- A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)CompletedNCT01533532Phase 2
- A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01692145Phase 2
- A Dose-finding Study of Silodosin in Patients With Urinary CalculiCompletedNCT01539265Phase 2